Jaime Noguez, Ph.D.

Speaker: Jaime Noguez, Ph.D
Medical Director of Chemistry and Toxicology at University Hospitals Cleveland Medical Center; Assistant Professor of Pathology at Case Western Reserve University

This webinar, hosted by Labroots and sponsored by Thermo Fisher Scientific, was recorded on October 14, 2020.

Dr. Jaime Noguez is the Medical Director of Chemistry and Toxicology at University Hospitals Cleveland Medical Center. She also serves as an Assistant Professor of Pathology at Case Western Reserve University. Dr. Noguez earned her PhD in Chemistry from the University of South Florida and completed her postdoctoral training in clinical chemistry at Emory University. She is a diplomat of the American Board of Clinical Chemistry and is actively involved in the American Association of Clinical Chemistry. Her primary research interests include patient safety, test utilization, and assay development with a focus on methods for drug analysis. Dr. Noguez has played an integral role in the local response to the opioid crisis in Northeast Ohio by developing mass spectrometry based diagnostics to combat controlled substance abuse.

Do you need help in planning your drug testing protocols? Did you know that a “one size fits all” approach to drug testing does not apply to all clinical scenarios? Drug testing for a patient in the emergency room is much different than perinatal drug testing or even prescription compliance monitoring for a patient in a treatment program. Knowing the clinical scenario can help you to select the most appropriate drug testing approach and test panel components for that clinical need. It can also guide other important decisions such as analytical test characteristics and result turnaround time requirements.

A critical first step for ensuring that your drug-testing program aligns with the clinical goals is to understand how the urine testing process works and what drug testing can and cannot tell you. This webinar will introduce the concept of toxicology testing, describe the different types of testing available, and highlight the many facets of drug testing in the clinical setting. It will provide several tools to help you define drug test panels and testing strategies for your laboratory as well as approaches to ensure that they remain relevant as the toxicology landscape continues to evolve.

Learning Objectives:

  • Discuss the various clinical scenarios where drug testing is requested on patients 
  • Determine appropriate drug testing panels for the various clinical needs
  • Explain the various technologies used in drug testing and their appropriateness based on clinical need